TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/5/17 19:31 | 8/31/17 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Pelossof Avi | MA | O | GlobalP, | M.d | 0 | 0.00 | 0 | 7 | 34 | 26 | D | ||||||||||||||
2/21/17 18:22 | 2/16/17 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Pelossof Avi | MA | O | GlobalP, | M.d | 0 | 0.00 | 23 | 10 | 81 | 22 | D | -8 | -25 | 0 | 5 | 2 | 8 | 4 | -1 | 0 | -1 | -4 | |||
1/4/17 19:16 | 12/30/16 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Pelossof Avi | MA | O | GlobalP, | M.d | 1,548 | 38.70 | 30 | 40 | 16 | D | 4 | -1 | -1 | -10 | 0 | 4 | -3 | 0 | 1 | 3 | -2 | 1 | |||
9/13/16 17:26 | 9/9/16 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Pelossof Avi | MA | O | GlobalP, | M.d | 0 | 0.00 | 33 | 7 | 75 | 16 | D | 17 | -18 | -20 | 1 | 16 | 7 | 10 | 2 | 0 | 2 | 0 | -12 | -14 | |
9/2/15 16:51 | 8/31/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Pelossof Avi | MA | O | GlobalP, | M.d | 0 | 0.00 | 33 | 7 | 304 | 9 | D | 64 | 41 | 11 | -2 | -2 | -5 | -4 | -3 | 0 | 1 | -4 | -20 | 4 | -25 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |